Enzo Biochem, Inc. (ENZB)
OTCMKTS · Delayed Price · Currency is USD
0.69887
+0.01137 (1.65%)
Inactive · Last trade price on Aug 19, 2025

Enzo Biochem Financials Overview

Millions USD. Fiscal year is Aug - Jul.

Revenue & Profits

Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingApr '25 Jul '24 Jul '23 Jul '22 Jul '21 Jul '20
Revenue
27.4731.9131.0632.64117.7376.02
Revenue Growth
-17.59%2.72%-4.85%-72.27%54.87%-6.34%
Gross Profit
11.7714.6311.5713.4353.5823.77
Operating Income
-11.28-12.37-24.74-17.530.69-30.37
Net Income
-21.08-26.0820.29-18.267.88-28.52
Earnings Per Share
-0.40-0.510.41-0.380.16-0.60
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingApr '25 Jul '24 Jul '23 Jul '22 Jul '21 Jul '20
Cash & Investments
36.6952.3782.3721.643.547.87
Total Debt
33.5179.2622.6832.79
Net Cash (Debt)
33.6948.8675.3812.3520.8315.08
Net Cash Growth
-32.48%-35.17%510.42%-40.71%38.15%-72.67%
Net Cash Per Share
0.650.961.530.250.430.32

Cash Flow & CapEx

Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingApr '25 Jul '24 Jul '23 Jul '22 Jul '21 Jul '20
Operating Cash Flow
-15.32-26.26-36.98-16.590.39-17.18
Capital Expenditures
-1.03-0.55-2.76-3.47-4.44-2.17
Free Cash Flow
-16.35-26.8-39.74-20.06-4.05-19.35
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingApr '25 Jul '24 Jul '23 Jul '22 Jul '21 Jul '20
Gross Margin
42.83%45.86%37.24%41.14%45.51%31.27%
Operating Margin
-41.06%-38.75%-79.64%-53.69%0.59%-39.95%
Pretax Margin
-28.54%-30.77%-80.56%-62.31%6.69%-37.52%
Profit Margin
-76.73%-81.73%65.32%-55.94%6.69%-37.52%
FCF Margin
-59.50%-84.01%-127.93%-61.46%-3.44%-25.45%

Dividends

Fiscal YearCurrentFY 2024
Period EndingJul '26 Jul '24
Dividend Per Share
0.1000.100
Dividend Per Share Growth
--
Dividend Yield
14.31%9.62%

Valuation

Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingJul '26 Jul '24 Jul '23 Jul '22 Jul '21 Jul '20
PE Ratio
--3.63-20.07-
PS Ratio
1.331.842.373.541.341.50